Absci Corp
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
ABSI | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00091E1091
- LEI:
- Country:
- United States of America
- Address:
- 18105 SE MILL PLAIN BLVD, 98683 VANCOUVER
- Website:
- https://www.absci.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Absci Corporation is a generative AI drug creation company focused on developing next-generation biologic therapeutics. The company's Integrated Drug Creation Platform combines scalable wet lab technologies with artificial intelligence to discover novel targets and design differentiated biologics, such as antibodies. Its process involves iterative cycles of data generation, AI model training, and laboratory validation to perform de novo design and multi-parametric lead optimization. Absci also utilizes a Reverse Immunology approach for AI-enabled target discovery. The company collaborates with pharmaceutical, technology, and academic partners to advance a pipeline of internal and partnered programs, aiming to accelerate the development of new medicines for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Absci Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Absci Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Absci Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
